Intrinsic Value of S&P & Nasdaq Contact Us

Bicycle Therapeutics plc BCYC

NASDAQ Global Select

SharesGrow Score
54/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$11.00
+117.4%

Bicycle Therapeutics plc (BCYC) current share price is $5.06. The gold spot price is $4,825.20 per troy ounce. Using the formula: BCYC in gold = $5.06 × 31.1035 ÷ $4,825.20 = 0.0326 grams of gold per share.

The Real Wealth Growth Rate measures the Compound Annual Growth Rate (CAGR) of BCYC when denominated in gold. A positive rate means the stock has outperformed gold as a store of value, while a negative rate indicates gold has been a better wealth preserver than holding BCYC shares over the measured period.

BCYC in US Dollars
Gold in US Dollars
BCYC in Gold (grams per share)

Real Wealth Growth Rate

BCYC
Computing…

"Real Wealth Growth Rate" measures the annualised compound growth rate (CAGR) of a stock when priced in gold — hard money that cannot be printed. A positive value means genuine wealth creation. A negative value means purchasing power is shrinking, even if the dollar price rises.

Step 1 — Express share price in grams of gold
$$\text{BCYC}_{\text{gold}}(t) = \frac{P_{\text{BCYC}}(t) \times 31.1035}{P_{\text{gold}}(t)}$$
$P_\text{BCYC}$ = stock price in USD, $P_\text{gold}$ = gold spot in USD/troy oz, $31.1035$ = grams per troy ounce.
Step 2 — Real Wealth Growth Rate (CAGR in gold terms)
$$\text{Real Wealth Growth Rate} = \left(\frac{\text{BCYC}_{\text{gold}}^{(T)}}{\text{BCYC}_{\text{gold}}^{(0)}}\right)^{\!\frac{1}{T}} - 1$$
$\text{BCYC}_\text{gold}^{(0)}$ = initial gold-price, $\text{BCYC}_\text{gold}^{(T)}$ = current gold-price, $T$ = number of years. A positive result means the stock outpaces gold.

Real Wealth Growth Rate Rankings — 20 Years

Computing…

People Also View

MRUS
MRUS
Merus N.V.
$90.00
+0.00%
IDYA
IDYA
IDEAYA Biosciences, Inc.
$32.35
-1.43%
STOK
STOK
Stoke Therapeutics, Inc.
$35.86
+2.31%
ANAB
ANAB
AnaptysBio, Inc.
$70.22
+2.17%
MLYS
MLYS
Mineralys Therapeutics, Inc.
$27.32
+0.59%
INBX
INBX
Inhibrx Biosciences, Inc.
$83.19
+7.40%
GLUE
GLUE
Monte Rosa Therapeutics, Inc.
$17.50
-0.28%
ORIC
ORIC
ORIC Pharmaceuticals, Inc.
$10.53
+1.25%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message